Skip to Main Content

Paper Details

Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC).
Cancers (Basel)
3
2021
Author NameAffiliation
Zhengping ZhuangCenter for Cancer Research, National Cancer Institute
  • 1 - 1

Datasets

Release 1.2